Health & Fitness News February 1, 2024 Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer February 1, 2024 Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales January 31, 2024 We're trimming a health-care stock ahead of earnings — hedging our bets on business in China January 31, 2024 Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments January 31, 2024 GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost January 31, 2024 Norway's giant wealth fund touts possibility of Novo Nordisk, Eli Lilly joining the trillion-dollar club January 31, 2024 Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars January 30, 2024 Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain January 30, 2024 Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat « Previous 1 2 3 4 … 17 18 19 20 21 22 23 Next »
February 1, 2024 Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer
January 31, 2024 We're trimming a health-care stock ahead of earnings — hedging our bets on business in China
January 31, 2024 Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024 GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024 Norway's giant wealth fund touts possibility of Novo Nordisk, Eli Lilly joining the trillion-dollar club
January 30, 2024 Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain